Damager Iben, Buchini Sabrina, Amaya Maria F, Buschiazzo Alejandro, Alzari Pedro, Frasch Alberto C, Watts Andrew, Withers Stephen G
Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia, V6T1Z1 Canada.
Biochemistry. 2008 Mar 18;47(11):3507-12. doi: 10.1021/bi7024832. Epub 2008 Feb 20.
The trans-sialidase from Trypanosoma cruzi catalyzes the transfer of a sialic acid moiety from sialylated donor substrates to the terminal galactose moiety of lactose and lactoside acceptors to yield alpha-(2,3)-sialyllactose or its derivatives with net retention of anomeric configuration. Through kinetic analyses in which the concentrations of two different donor aryl alpha-sialoside substrates and the acceptor substrate lactose were independently varied, we have demonstrated that this enzyme follows a ping-pong bi-bi kinetic mechanism. This is supported for both the native enzyme and a mutant (D59A) in which the putative acid/base catalyst has been replaced by the demonstration of the half-reaction in which a sialyl-enzyme intermediate is formed. Mass spectrometric analysis of the protein directly demonstrates the formation of a covalent intermediate, while the observation of release of a full equivalent of p-nitrophenol by the mutant in a pre-steady state burst provides further support. The active site nucleophile is confirmed to be Tyr342 by trapping of the sialyl-enzyme intermediate using the D59A mutant and sequencing of the purified peptic peptide. The role of D59 as the acid/base catalyst is confirmed by chemical rescue studies in which activity is restored to the D59A mutant by azide and a sialyl azide product is formed.
克氏锥虫的转唾液酸酶催化唾液酸化供体底物上的唾液酸部分转移至乳糖和乳糖苷受体的末端半乳糖部分,生成α-(2,3)-唾液酸乳糖或其衍生物,同时端基异构构型净保留。通过动力学分析,其中两种不同的供体芳基α-唾液酸苷底物和受体底物乳糖的浓度被独立改变,我们证明该酶遵循乒乓双底物动力学机制。这一点在天然酶和一个突变体(D59A)中均得到支持,在该突变体中,假定的酸碱催化剂已被替换,通过形成唾液酰酶中间体的半反应得以证明。对该蛋白质的质谱分析直接证明了共价中间体的形成,而在预稳态猝发中观察到突变体释放出一当量的对硝基苯酚则提供了进一步的支持。通过使用D59A突变体捕获唾液酰酶中间体并对纯化的胃蛋白酶肽进行测序,确认活性位点亲核试剂为Tyr342。通过化学拯救研究证实了D59作为酸碱催化剂的作用,在该研究中,叠氮化物使D59A突变体恢复活性,并形成了唾液酰叠氮产物。